Analysed ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) News Sources
Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
14-04-2026
yahoo.com
Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers
24-03-2026
yahoo.com
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors
09-03-2026
yahoo.com
Actuate Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
24-02-2026
yahoo.com
Actuate Therapeutics, Inc.'s (NASDAQ:ACTU) market cap dropped US$13m last week; Private equity firms bore the brunt
04-02-2026
yahoo.com
Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers
21-01-2026
yahoo.com
Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overall Survival Benefit with Elraglusib Plus Chemotherapy for Metastatic Pancreatic Cancer in Oral Presentation at ASCO GI 2026
12-01-2026
yahoo.com
Actuate Therapeutics Plans to Advance Elraglusib in Ewing Sarcoma After Phase 1 Data
06-01-2026
yahoo.com
What is the current price of ACTUATE THERAPEUTICS INC (ACTU:NASDAQ)?
The current price of ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) is $2.31.
ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) since the previous trading day is $0.16.
ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) since the previous trading day is 7.4419%.
What is the most recent average sentiment score for ACTUATE THERAPEUTICS INC (ACTU:NASDAQ)?
The most recent average sentiment score for ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for ACTUATE THERAPEUTICS INC (ACTU:NASDAQ)?
The most recent sentiment for ACTUATE THERAPEUTICS INC (ACTU:NASDAQ) is .
SEC-8K** Filing Available For ACTUATE THERAPEUTICS INC (ACTU:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.